Skip to main content
Log in

Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background. Immediate breast reconstruction (IBR) by means of skin expander is currently one of the most widely used methods of breast reconstruction in mastectomized patients. However, given that many breast cancer patients usually receive adjuvant chemotherapy, the adoption of IBR raises new questions concerning possible cumulative toxicity. The present study reports our experience in the use of concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expander after mastectomy for breast cancer and the acute cumulative toxicity of the treatments.

Methods. We evaluated a consecutive series of 52 breast cancer patients who have received IBR by skin expander after radical mastectomy and adjuvant chemotherapy concurrently during skin expansion between 1995 and 1998 (IBR/CT group). We identified two series of control patients treated during the same period: 51 consecutive patients undergoing radical mastectomy and IBR without adjuvant chemotherapy (IBR group) and 63 consecutive patients undergoing radical mastectomy and adjuvant chemotherapy without IBR (CT group). For each patient, we evaluated the incidence of surgical complications and chemotherapy's side effects and dose intensity.

Results. The interval between surgery and the start of expander inflation was similar in IBR/CT (range 0–19, median 5 days) and IBR groups (range 0–40, median 5 days) and the timing of inflation was not influenced by chemotherapy. The overall incidence of surgical complications in patients undergoing IBR was low: seroma in eight cases, infection in one, skin necrosis in one, expander rupture in two and erythema in three. There were no statistically significant differences in the distribution of complications between the IBR/CT and IBR groups. The dose intensity of chemotherapy was similar between IBR/CT and CT groups, with a median dose intensity of 96% and 95% of the projected dose, respectively. The only statistically significant difference in terms of chemotherapy side effects (p=0.03) was that stomatitis was more frequent and intense in the CT than in the IBR/CT group.

Conclusions. Concurrent treatment with IBR and adjuvant chemotherapy appears feasible and safe, it does not increase acute surgical complications or chemotherapy side effects, and does not require any changes in dose intensity or the timing of inflation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Irwig L, Bennetts A: Quality of life after breast conservation or mastectomy: a systematic review. Aust N Z J Surg 67: 750–754, 1997

    Google Scholar 

  2. Noone RB, Frazier TG, Hayward CZ, Skiles MS: Patient acceptance of immediate reconstruction following mastectomy. Plast Reconstr Surg 69: 632–640, 1982

    Google Scholar 

  3. Dean C, Chetty U, Forrest APM: Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet 1: 459–462, 1983

    Google Scholar 

  4. Stevens LA, McGrath MH, Druss RG, Kister SJ, Gump FE, Forde KA: The psychological impact of immediate breast reconstruction for women with early breast cancer. Plast Reconstr Surg 73: 619–626, 1984

    Google Scholar 

  5. Schain WS, Wellisch DK, Pasnau RO, Landsverk J: The sooner the better: a study of psychological factors in women undergoing immediate versus delayed breast reconstruction. Am J Psychiatry 142: 40–46, 1985

    Google Scholar 

  6. Wellisch DK, SchainWS, Noone RB, Little JWI: Psychosocial correlates of immediate versus delayed reconstruction of the breast. Plast Reconstr Surg 76: 713–718, 1985

    Google Scholar 

  7. Bailey MH, Smith JW, Casas L, Johnson P, Serra E, de la Fuente R, Sullivan M, Scanlon EF: Immediate breast reconstruction: reducing the risks. Plast Reconstr Surg 83: 845–851, 1989

    Google Scholar 

  8. Yule GJ, Concannon MJ, Croll GH, Puckett CL: Is there liability with chemotherapy following immediate breast reconstruction? Plast Reconstr Surg 97: 969–973, 1996

    Google Scholar 

  9. Wey PD, Highstein JB, Borah GL: Immediate breast reconstruction in the high-risk adjuvant setting. Ann Plast Surg 38: 342–344, 1997

    Google Scholar 

  10. Furey PC, MacGillivray DC, Castiglione CL, Allen L: Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol 55: 194–197, 1994

    Google Scholar 

  11. Hoffluan JP, Kusiak J, Boraas M, Genter B, Steuber K, Weese JL, Keidan RD, Eisenberg BL, Cox T, Litwin S: Risk factors for immediate prosthetic postmastectomy reconstruction. Am Surg 57: 514–521, 1991

    Google Scholar 

  12. Longo DL, Duffey PL, DeVita VT, Wesley MN, Hubbard SM, Young RC: The calculation of actual or received dose intensity: A comparison of published method. J Clin Oncol 9: 2042–2051, 1991

    Google Scholar 

  13. Silverstein MJ, Murphy GP, Bostwick J, Byrd BFJ, Snyderman RK, Weber WE: Breakout II: Breast reconstruction: State of the art for the 1990's. Cancer 68: 1180–1181, 1991

    Google Scholar 

  14. Argenta LC, Marks MW, Grabb WC: Selective use of serial expansion in breast reconstruction. Ann Plast Surg 11: 188–195, 1983

    Google Scholar 

  15. Albo R, Gruber R, Kahn R: Immediate breast reconstruction after modified mastectomy for carcinoma of the breast. Am J Surg 140: 131–136, 1980

    Google Scholar 

  16. Georgiade G, Georgiade N, McCarty KS, Seigler HF: Rationale for immediate reconstruction of the breast following modified radical mastectomy. Ann Plast Surg 8: 20–28, 1982

    Google Scholar 

  17. Frazier TG, Noone RB: An objective analysis of immediate simultaneous reconstruction in the treatment of carcinoma of the breast. Cancer 55: 1202–1205, 1985

    Google Scholar 

  18. Feller WF, Holt R, Spear S, Little JW: Modified radical mastectomy with immediate breast reconstruction. Am Surg 52: 129–133, 1986

    Google Scholar 

  19. Noone RB, Murphy JB, Spear SL, Little JWI: A six year experience with immediate reconstruction after mastectomy for cancer. Plast Reconstr Surg 76: 258–269, 1985

    Google Scholar 

  20. Johnson CH, van Heerden JA, Donohue JH, Martin JK, Jackson IT, I1strup DM: Oncological aspects of immediate breast reconstruction following mastectomy for malignancy. Am Surg 24: 819–824, 1989

    Google Scholar 

  21. Kroll SS, Ames F, Singletary SE, Schusterman MA: The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg Gynecol Obstet 172: 17–20, 1991

    Google Scholar 

  22. Devereux DF, Thibault L, Boretos J, Brennan MF: The quantitative and qualitative impairment of wound healing by Adriamycin. Cancer 43: 932–938, 1979

    Google Scholar 

  23. Ferguson MK: The effect of antineoplastic agents on wound healing. Surg Gynecol Obstet 154: 421–429, 1982

    Google Scholar 

  24. Lawrence WT, Talbot TL, Norton JA: Preoperative or postoperative doxorubicin hydrochloride (Adriamycin): which is better for wound healing? Surgery 100: 9–13, 1986

    Google Scholar 

  25. Pollack SV: Systemic drugs and nutritional aspects of wound healing. Clin Dermatol 2: 68–80, 1984

    Google Scholar 

  26. Angerpointner TA, Schmidt P, Donhauser U, Haas R, Bender-Gotze C: Postoperative course in children with malignant tumors following preoperative chemotherapy. Klin Pediatr 201: 209–212, 1989

    Google Scholar 

  27. McDonald DJ, Capanna R, Gherlinzoni F, Bacci G: Influence of chemotherapy on perioperative complications in limb salvage surgery for bone tumors. Cancer 65: 1509–1516, 1990

    Google Scholar 

  28. FowlerWC, Langer CJ, CurranWJJ, Keller SM: Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55: 986–989, 1993

    Google Scholar 

  29. Georgiade GS, Riefkohl R, Cox E, McCarty KS, Seigler HF, Georgiade NG, Snowhite JC: Long-term clinical outcome of immediate breast reconstruction after mastectomy. Plast Reconstr Surg 76: 415–420, 1985

    Google Scholar 

  30. Noone RB, Frazier TG, Noone GC, Blanchet NP, Murphy JB, Rose D: Recurrence of breast carcinoma following immediate reconstruction: a 13-year review. Plast Reconstr Surg 93: 96–106, 1994

    Google Scholar 

  31. van Heerden JA, Jackson IT, Martin JK, Fisher I: Surgical technique and pitfalls of breast reconstruction immediately after mastectomy for carcinoma: initial experience. Mayo Clin Proc 62: 185–191, 1987

    Google Scholar 

  32. Rheingold L, Yoo RP, Courtiss EH: Experience with 326 inflatable breast implants. Plast Reconstr Surg 93: 118–122, 1994

    Google Scholar 

  33. Forouhi P, Dixon JM, Leonard RCF, Chetty U: Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. Br J Surg 82: 79–82, 1995

    Google Scholar 

  34. Danforth DNj, Lippman ME, McDonald H, Bader J, Egan E, Lampert M, Steinberg SM, Swain SM: Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. Am Surg 56: 6–11, 1990

    Google Scholar 

  35. Broadwater JR, Edwards MJ, Kuglen C, Hortobagyi GN, Ames FC, Balch CM: Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity. Ann Surg 213: 126–129, 1991

    Google Scholar 

  36. Camilleri IG, Malata CM, Stavrianos S, McLean NR: A review of 120 Becker permanent tissue expanders in reconstruction of the breast. Br J Plast Surg 49: 346–351, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caffo, O., Cazzolli, D., Scalet, A. et al. Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer. Breast Cancer Res Treat 60, 267–275 (2000). https://doi.org/10.1023/A:1006401403249

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006401403249

Navigation